0001209191-18-052076.txt : 20180924 0001209191-18-052076.hdr.sgml : 20180924 20180924181252 ACCESSION NUMBER: 0001209191-18-052076 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180924 FILED AS OF DATE: 20180924 DATE AS OF CHANGE: 20180924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patterson Matthew R CENTRAL INDEX KEY: 0001401018 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37833 FILM NUMBER: 181084349 MAIL ADDRESS: STREET 1: C/O AMICUS THERAPEUTICS, INC. STREET 2: 6 CEDAR BROOK DRIVE CITY: CRANBURY STATE: NJ ZIP: 08512 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Audentes Therapeutics, Inc. CENTRAL INDEX KEY: 0001628738 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 461606174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 BUSINESS PHONE: 415-638-6556 MAIL ADDRESS: STREET 1: 600 CALIFORNIA ST., 17TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-24 0 0001628738 Audentes Therapeutics, Inc. BOLD 0001401018 Patterson Matthew R C/O AUDENTES THERAPEUTICS, INC. 600 CALIFORNIA STREET, 17TH FLOOR SAN FRANCISCO CA 94108 1 1 0 0 Chief Executive Officer Common Stock 2018-09-24 4 M 0 15000 0.78 A 15000 D Common Stock 171814 I By Matthew R. Patterson Revocable Trust Stock Option (right to buy) 0.78 2018-09-24 4 M 0 15000 0.00 D 2023-09-25 Common Stock 15000 92702 D The reporting person is the trustee of the Matthew R. Patterson Revocable Trust. The option vested as to 25% of the total shares on January 1, 2014, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on January 1, 2017, subject to the reporting person's provision of service to the issuer on each vesting date and to accelerated vesting in the event of the occurrence of certain events. /s/ Thomas Soloway as attorney-in-fact for Matthew Patterson 2018-09-24